Overall, STAT3/5 targeting siRNA is proven to promote apoptosis, cell cycle arrest, and suppress cancer cell invasion in various carcinoma cell-line models, including prostate, esophageal, hepatocellular, ovarian, laryngeal, breast, and colorectal cancer (139–146). Here, STAT3 is linked to carcinoma.